We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+9.2%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$3.36B
AUM Growth
-$521M
Cap. Flow
-$561M
Cap. Flow %
-16.68%
Top 10 Hldgs %
31.32%
Holding
2,193
New
694
Increased
377
Reduced
430
Closed
579
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYRS
1476
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$77K ﹤0.01%
1,420
-40
-3% -$2.37K
AAC.WS
1477
DELISTED
Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AAC.WS
$74K ﹤0.01%
59,500
+2,500
+4% +$2.64K
III icon
1478
Information Services Group
III
$251M
$73K ﹤0.01%
+12,564
New +$65.1K
QMCO icon
1479
Quantum Corp
QMCO
$474M
$70K ﹤0.01%
+507
New +$82K
BTMDW
1480
DELISTED
Biote Corp. Warrant
BTMDW
$68K ﹤0.01%
+64,300
New +$55.6K
KIIIW
1481
DELISTED
Kismet Acquisition Three Corp. Warrant
KIIIW
$67K ﹤0.01%
+82,566
New +$54.6K
GROW icon
1482
US Global Investors
GROW
$38.5M
$66K ﹤0.01%
10,703
-293,433
-96% -$2.09M
LITS
1483
Lite Strategy Inc
LITS
$30.9M
$66K ﹤0.01%
1,150
APGB.WS
1484
DELISTED
Apollo Strategic Growth Capital II Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
APGB.WS
$66K ﹤0.01%
+52,200
New +$56.1K
AFAQW
1485
DELISTED
AF Acquisition Corp Warrants
AFAQW
$66K ﹤0.01%
+75,199
New +$57.3K
TETCW
1486
DELISTED
Tech and Energy Transition Corporation Warrant
TETCW
$65K ﹤0.01%
+64,699
New +$54K
NRACW
1487
DELISTED
Northern Revival Acquisition Corporation Warrant
NRACW
$64K ﹤0.01%
75,381
+8,381
+13% +$6.08K
ASXC
1488
CALL
DELISTED
Asensus Surgical, Inc.
ASXC
$62K ﹤0.01%
19,500
-1,900
-9% -$4.75K
TLGA.WS
1489
DELISTED
TLG Acquisition One Corp. Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
TLGA.WS
$61K ﹤0.01%
77,234
+8,068
+12% +$5.19K
HYMCW
1490
DELISTED
Hycroft Mining Holding Corporation Warrant
HYMCW
$59K ﹤0.01%
122,678
-20,984
-15% -$12.2K
ZCMD icon
1491
Zhongchao
ZCMD
$6.65M
$59K ﹤0.01%
+4
New +$53.8K
MITT
1492
CALL
TPG Mortgage Investment Trust
MITT
$225M
$57K ﹤0.01%
4,467
-2,533
-36% -$31.6K
FMIVW
1493
DELISTED
Forum Merger IV Corporation Warrant
FMIVW
$54K ﹤0.01%
+42,350
New +$48.5K
PNTM.WS
1494
DELISTED
Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PNTM.WS
$52K ﹤0.01%
+52,430
New +$43.3K
AGAC.WS
1495
DELISTED
African Gold Acquisition Corp Warrants
AGAC.WS
$51K ﹤0.01%
+81,220
New +$40.6K
SOLO
1496
CALL
DELISTED
Electrameccanica Vehicles Corp. Ltd.
SOLO
$47K ﹤0.01%
11,000
-17,200
-61% -$70.7K
EACPW
1497
DELISTED
Edify Acquisition Corp. Warrant
EACPW
$47K ﹤0.01%
+66,451
New +$39.1K
ASAXW
1498
DELISTED
Astrea Acquisition Corp. Warrant
ASAXW
$47K ﹤0.01%
71,061
+60,273
+559% +$32.6K
LEGOW
1499
DELISTED
Legato Merger Corp. Warrant
LEGOW
$45K ﹤0.01%
24,202
+13,431
+125% +$12.9K
LGACW
1500
DELISTED
Lazard Growth Acquisition Corp. I Warrants
LGACW
$42K ﹤0.01%
+36,579
New +$39K

Similar funds

Prelude Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Prelude Capital Management held 2,193 positions worth $3.36B, down 13% from $3.89B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Prelude Capital Management withdrew a net $561M in Q2 2021, closing 579 positions and reducing 430 holdings. Its most notable exit was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $39.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 9% of assets, up from 6.6% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Prelude Capital Management opened a new position in KKR Acquisition Holdings I Corp. worth $36.3M.

  • Prelude Capital Management's largest Q2 2021 buy was KKR Acquisition Holdings I Corp.: 3,700,000 shares worth $36.3M.
  • Prelude Capital Management added most to PRA Health Sciences, Inc. in Q2 2021, an estimated $19.4M increase.
  • Prelude Capital Management's biggest Q2 2021 reduction was Micron Technology, cutting an estimated $7.72M.
  • Prelude Capital Management fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2021, selling an estimated $39.4M.
  • Prelude Capital Management's ten largest holdings make up 31% of its $3.36B portfolio in Q2 2021.
  • Prelude Capital Management opened 694 new positions and closed 579 in Q2 2021.
  • Prelude Capital Management's portfolio value fell 13% quarter-over-quarter to $3.36B.

Based on Prelude Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.